Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

, , , ,

 

(Reuters) – Johnson & Johnson said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The drugmaker already has a mid-stage HIV vaccine study underway in five southern African countries.

There are currently no vaccines for HIV, a virus that weakens the body’s immune system.

 

Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila

 

Reuters source:

https://www.reuters.com/article/us-johnson-johnson-hiv/johnson-johnson-to-test-experimental-hiv-vaccine-in-u-s-europe-idUSKCN1U720D